iSonea products recognised at CES
iSonea (ASX:ISN) has revealed that its asthma monitoring technology was selected to receive a digital technology award at the Consumer Electronics Show, held in Las Vegas in early January.
The company has been given a Tech Podcast Network Innovator Pick Award for its AirSonea wheeze monitoring device.
AirSonea launched in Australia in September last year. The product also has CE Mark approval in Europe, and iSonea is aiming for a US launch this year.
The award also recognises iSonea’s AsthmaSense Prime, the smartphone app used to keep tabs on asthma symptoms.
AsthmaSense Prime uses symptoms, triggers, environmental factors and medication usage statistics to inform patients about changing asthma risks.
iSonea last year added cloud capabilities to its AsthmaSense symptom monitoring system and received a Frost & Sullivan Innovation Award for its efforts.
iSonea (ASX:ISN) shares were trading 4.11% higher at $0.38 as of around 1 pm on Thursday.
Diabetes changes the structure of our hearts, study finds
Type 2 diabetes directly alters the heart's structure and energy systems, which explains why...
Beta blockers could halt triple negative breast cancer
Researchers have identified a molecular biomarker in triple negative breast cancer tumours which...
Common arthritis drug also lowers blood pressure
Scientists have known for a while that methotrexate helps with inflammation, but it may also help...
